"Z(AV0Z40550506)" . "4"^^ . "4"^^ . "Z\u00EDdkov\u00E1, J." . . "N\u00E1dorov\u00E9 markery a jejich vyu\u017Eit\u00ED v klinick\u00E9 praxi"@cs . "N\u00E1dorov\u00E9 markery a jejich vyu\u017Eit\u00ED v klinick\u00E9 praxi" . . "152773" . "RIV/61388963:_____/12:00377913!RIV13-AV0-61388963" . "RIV/61388963:_____/12:00377913" . "106" . "1"^^ . "000299579700004" . "N\u00E1dorov\u00E9 markery a jejich vyu\u017Eit\u00ED v klinick\u00E9 praxi"@cs . "0009-2770" . . "prostate-specific antigen; P53; cancer; population"@en . . . "CZ - \u010Cesk\u00E1 republika" . "Chemick\u00E9 listy" . "Tumorov\u00E9 markery zn\u00E1m\u00E9 tak\u00E9 jako rakovinn\u00E9 nebo onkologick\u00E9 markery jsou molekuly b\u00EDlkovinn\u00E9 povahy produkovan\u00E9 jak n\u00E1dorov\u00FDmi tak nen\u00E1dorov\u00FDmi bu\u0148kami organismu p\u0159i malign\u00EDm zvratu. Rakovinn\u00E9 markery se vyu\u017E\u00EDvaj\u00ED pro detekci, ur\u010Den\u00ED diagn\u00F3zy, progn\u00F3zy a kontrolu \u00FAsp\u011B\u0161nosti l\u00E9\u010Dby rakovinn\u00FDch onemocn\u011Bn\u00ED. V sou\u010Dasn\u00E9 dob\u011B neexistuje univerz\u00E1ln\u00ED specifick\u00FD rakovinn\u00FD marker, proto se v klinick\u00E9 praxi vyu\u017E\u00EDv\u00E1 \u0159ada r\u016Fzn\u00FDch marker\u016F specifick\u00FDch pro ur\u010Dit\u00FD typ rakovinn\u00E9ho onemocn\u011Bn\u00ED. Nev\u00FDhodou rakovinn\u00FDch marker\u016F je fale\u0161n\u00E1 pozitivita za ur\u010Dit\u00FDch fyziologick\u00FDch i patologick\u00FDch stav\u016F nesouvisej\u00EDc\u00EDch s rakovinn\u00FDm onemocn\u011Bn\u00EDm." . . "Tumor Markers and Their Use in Clinical Practice"@en . . . "Tumorov\u00E9 markery zn\u00E1m\u00E9 tak\u00E9 jako rakovinn\u00E9 nebo onkologick\u00E9 markery jsou molekuly b\u00EDlkovinn\u00E9 povahy produkovan\u00E9 jak n\u00E1dorov\u00FDmi tak nen\u00E1dorov\u00FDmi bu\u0148kami organismu p\u0159i malign\u00EDm zvratu. Rakovinn\u00E9 markery se vyu\u017E\u00EDvaj\u00ED pro detekci, ur\u010Den\u00ED diagn\u00F3zy, progn\u00F3zy a kontrolu \u00FAsp\u011B\u0161nosti l\u00E9\u010Dby rakovinn\u00FDch onemocn\u011Bn\u00ED. V sou\u010Dasn\u00E9 dob\u011B neexistuje univerz\u00E1ln\u00ED specifick\u00FD rakovinn\u00FD marker, proto se v klinick\u00E9 praxi vyu\u017E\u00EDv\u00E1 \u0159ada r\u016Fzn\u00FDch marker\u016F specifick\u00FDch pro ur\u010Dit\u00FD typ rakovinn\u00E9ho onemocn\u011Bn\u00ED. Nev\u00FDhodou rakovinn\u00FDch marker\u016F je fale\u0161n\u00E1 pozitivita za ur\u010Dit\u00FDch fyziologick\u00FDch i patologick\u00FDch stav\u016F nesouvisej\u00EDc\u00EDch s rakovinn\u00FDm onemocn\u011Bn\u00EDm."@cs . . "Tumor Markers and Their Use in Clinical Practice"@en . . . "1" . . "Br\u00E1zdov\u00E1, A." . "Tumor markers known also as cancer or oncological markers are substances produced either by tumor or normal cells as a response to the presence of cancer. The markers are used for the detection, diagnosis, prognosis and control of treatment. There is no absolutely specific or universal cancer marker; therefore different markers for different cancer types are used in clinical practice. A problematic feature of cancer markers is their falsely positive results under physiological and non-cancer conditions."@en . "[1D368D5CFB47]" . . . "Machov\u00E1, Iva" . "Fusek, M." . . . "N\u00E1dorov\u00E9 markery a jejich vyu\u017Eit\u00ED v klinick\u00E9 praxi" . .